STUDY QUESTION: What is the difference between the gene expression profiles of single human germinal vesicle (GV) oocytes from women of different ages?
Introduction
The reproductive lifespan of women is dependent on a finite number of primordial follicles that is set during foetal development and declines until menopause. Female fertility starts at puberty and decreases after the age of 30, followed by an accelerated decline between 35 and menopause (Menken et al., 1986; Leridon, 2004; Baird et al., 2005; Eijkemans et al., 2014 ). An inversed age-related pattern is seen for miscarriages, which increase with increasing female age (Nybo Andersen et al., 2000; Broekmans et al., 2009) . Decreased oocyte quality seems to be at least partially responsible for these phenomena. When older women receive young donor oocytes within oocyte donation treatments, older women display nearly identical pregnancy and miscarriages rates as young women (Navot et al., 1991; Schieve et al., 2003) . Additionally, one of the hallmarks of decreased oocyte quality with increasing female age is the higher incidence of aneuploidy of maternal origin in pre-implantation embryos, foetuses and newborns in older women (Hassold and Chiu, 1985; te Velde et al., 1998; Demko et al., 2016) .
Despite the well-established link between female age, oocyte quality and reproductive success, very little is known about the molecular mechanisms underlying this link. Potential mechanisms include telomere shortening, impaired mitochondrial function, genomic instability and transcriptome changes (Li et al., 2012; Lopez-Otin et al., 2013; Keefe, 2016; May-Panloup et al., 2016) . One of the reasons for the limited knowledge on the molecular mechanisms underlying decreased oocyte competence with increasing age is that molecular analysis of single oocytes is technically challenging. As maternal RNAs and proteins are stored in the oocyte from birth until fertilization, it seems likely that gene expression profiles of these oocytes might change over time and that these changes could underly the decreased competence with increasing age. In humans, only six studies have published results on the association between female age and gene expression profiles of human oocytes and all have their specific drawbacks (Table I ). Three out of six studies applied restrictive techniques such as quantitative high throughput PCR rather than whole transcriptome analyses (Fragouli et al., 2010; Guglielmino et al., 2011; Santonocito et al., 2013) . Of the three studies that applied whole transcriptome analysis, one used pooled rather than single human oocytes (Steuerwald et al., 2007) . The last two studies did study single (unfertilized) oocytes, but they both included very few oocytes (n = 15 and n = 10) and only focused on two different female age groups. More precisely, Grondahl et al., compared 10 single Metaphase II (M II) oocytes from women aged between 27 and 35 years to five M II oocytes from women aged between 37 and 39 years, and Reyes et al., studied germinal vesicle (GV) and M II oocytes from five young (<30 years) and five old (≥40 years) women. Furthermore, the M II oocytes in this study were matured in vitro, which is known to alter gene expression (Wells and Patrizio, 2008; Virant-Klun et al., 2013; Adona et al., 2016) .
We therefore examined the relationship between gene expression profiles of 40 human GV oocytes and female biological and chronological age, using a recently validated transcriptomics approach for single oocytes and embryos (Mantikou et al., 2016) .
Materials and Methods

Patients
Couples undergoing ICSI treatment at the Centre for Reproductive Medicine of the Academic Medical Centre Amsterdam, the Netherlands, between 2012 and 2014, were asked to give written informed consent to donate their spare GV oocytes. Only one oocyte per woman was included in the study. Since we used spare GV oocytes, ethical approval was not deemed necessary by the Central Ethics Committee on Research involving human subjects. However the study received ethical approval by the medical ethical committee. Women between 18 and 43 years of age were eligible to participate. GV oocytes from women of different ages were split into four groups: 25-30, 31-35, 36-38 and 39-43 years. These groups were based on the different phases in decline in fertility with female age.
Oocyte collection and treatment
Women's ovaries were stimulated according to local stimulation protocol. Pituitary down-regulation was achieved by a gonadotropin-releasing hormone agonist (triptorelin, Decapeptyl, Ferring) starting in the midluteal phase of the menstrual cycle. We conducted ovarian stimulation with Highly Purified Human Menopausal Gonadotrophin (Menopur, Ferring Pharmaceuticals) or recombinant FSH (follitropine, Puregon, Merck Sharp & Dohme or Gonal-F, Merck) starting on cycle Day 5. We continued ovarian stimulation until three or more follicles with a diameter of 18 mm had developed, after which ovulation was induced with 5000 or 10 000 IU of hCG (Pregnyl, Merck Sharp & Dohme) . After 36 h, follicles were aspirated under transvaginal ultrasound guidance. GV oocytes were immediately collected after follicular aspiration and donated for research. Oocyte morphology was assessed by the colour of the cytoplasm and presence of cumulus cells, with a light stereoscope (Nikon, SMZ800). In order to remove the zona pellucida and cumulus cells, oocytes were treated with 0.05% HCl/Tween 20. Next, we collected the individual GV oocytes in 0.2 ml tubes, which were snapped frozen in liquid nitrogen and stored at −80°C until RNA analysis. We conducted all manipulations rapidly to minimize the overall handling time and prevent RNA degradation.
Sample preparation, RNA isolation and amplification
For sample preparation, we used a protocol that was previously evaluated by our group and has been validated for the analysis of picogram amounts of RNA from single human oocytes (Mantikou et al., 2016) . We performed all preparations according to the instructions of the manufacturer. In short, RNA was isolated with the Arcturus PicoPure isolation kit (Applied biosystems) and optional DNase treatment was performed. We amplified RNA with the WT-Ovation One-Direct (Nugen) kit. Due to the SPIA-based method, the end product was cDNA. We determined the concentration of the cDNA with the NanoDrop ND-1000 (Thermo Scientific) and examined the quality of the cDNA with the BioAnalyzer (Agilent Technologies) using a Nano 6000 kit (Agilent Technologies 
Labelling and microarray hybridization
To minimize the technical variation during labelling, all samples were prepared at the same time. We labelled and purified 2 μg of sample cDNA with Cy3 and reference cDNA with Cy5 (SureTag DNA labelling kit, Agilent Technologies). We pooled 7 μg of each sample cDNA to use as a common reference. We determined the yield and specific activity of the labelled samples with the NanoDrop ND-1000 (Thermo Scientific). For microarrays, we used 4 × 180 K format containing~42.000 unique probes (Part number G4862A, design ID 028 004, Agilent Technologies). This array is identical to the standard 8 × 60 K Human Gene Expression Microarray from Agilent Technologies, except that every probe is printed four times to minimize technical variation.
The hybridization mixture contained 3 μg of individually labelled sample cDNA and 3 μg of common reference cDNA. We prepared the hybridization mixture according to the Two-Colour Microarray-Based Gene Expression Analysis protocol (Agilent Technologies) and loaded the array slides with the hybridization mixture. The array slides were hybridized at 65°C in a rotator at 10 rpm for 17 h. The slides were washed and scanned at 3 μm with the Agilent scanner GA2505C (Agilent Technologies). We labelled, hybridized and scanned all slides on the same day to minimize technical variation. Microarray data were extracted using Feature Extraction software 10.7.1 (Agilent Technologies).
Microarray data analysis
We subjected microarray data to a normal background correction, Loesswithin array normalization and analysed the data with the Limma package (Bioconductor). The arrayQualityMetrics package was used to assess the quality of the microarray data. We averaged replicate probes. Probes were annotated with the annotation file of the array designed by the MicroArray Department (MAD) of the Microarray facility of the University of Amsterdam. EntrezIDs and Ensemble GeneIDs were obtained with BioMart using the Gene Symbols as input. We assessed the differential gene expression with a moderated t-test using the linear model framework from the Limma package. A P-value of <0.01 was considered statistically significant. We applied this cut off to avoid an abundance of unadjusted false positive results. To correct for multiple testing of these resulting P-values, we performed the Benjamini-Hochberg false discovery rate (FDR) (Benjamini and Hochberg, 1995) . A FDR <0.05 was considered statistically significant.
To identify genes showing the highest variation in expression between the different age groups, we applied a cut off significance P-value of <0.05, in combination with an log FC of >1.5 as previously described by Grondahl et al. (2010) . Statistical analyses were performed using R (v3.1.0) and Bioconductor (v2.14).
Hierarchical cluster diagram and multidimensional scaling plot
We performed hierarchical clustering with the hclust function from the Rpackage stats and used the complete linkage method. To further visualize the sample relationships, we constructed multidimensional scaling (MDS) plots. The MDS procedure placed samples in a dimensional space preserving the between-sample Euclidean distances based on the top 500 most differing genes.
Linear regression analyses
We performed linear regression analysis for each gene with age as a covariate using the Limma R-package.
Cluster profiles of gene expression profiles
General trends of gene expression changes over the age groups and over time were analysed by the K-means clustering algorithm. We determined the number of K in K-means clustering by exploration of the robustness of the clusters of gene expression profiles. The clusters of gene expression profiles found should be relatively robust to changes in the number of K-means clusters, meaning that most of the clusters of gene expression profiles should be similarly independent of the number of clusters are found.
Gene ontology enrichment analysis
Enrichment analyses were performed to investigate overrepresentation of functional categories of the selected genes. The gene ontology analyses were performed by using the Database for Annotation, Visualization and the Integrated Discovery (DAVID) analysis wizard (http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009a,b) . All genes present on the array were used as a global reference background. The enrichment score is the geometric mean with a relative score instead of an absolute P-value. A minus log transformation is applied on the average P-values which means that an enrichment score of 1.3 is equivalent to non-log scale 0.05 (Huang da et al., 2009a,b) . We defined the functional category as significantly over-expressed or enriched if a functional group had an enrichment score above 1.3 (Huang da et al., 2009a,b) .
Results
Baseline characteristics
Two out of 40 oocyte samples did not pass our quality control criteria after normalization and were excluded from further analysis. The baseline characteristics of women from four age groups are shown in Table II . There were 10 GV oocytes were finally included in the 25-30 years group, 11 GV oocytes in the 31-35 years group, 8 GV oocytes in 36-38 years group and 9 GV oocytes in the 39-43 years group. As expected, increased female age correlated with both lower antral follicle count (AFC) (r = −0.64, P < 0.0001) and higher dosage of FSH needed for ovarian stimulation (r = 0.68, P < 0.0001).
Primary analysis
A total of 15 357 unique genes were expressed in the GV oocytes. We first determined the correlation between the gene expression profiles of the 38 GV oocytes and age, AFC and total dosage of FSH using hierarchical clustering and MDS plotting (Fig. 1) . Expression profiles of the GV oocytes were very heterogeneous. There was neither clear clustering based on the categories of female age nor in the categories AFC or the total dosage of FSH (Fig. 1A) . The wide variation in gene expression profiles between GV oocytes was confirmed in a MDS plot, in which oocytes of women of different ages seem to be spread randomly throughout the plot (Fig. 1B) .
Next, the expression values of 42 489 individual probes of the 15 357 unique genes were compared between the four age groups. A total of 189 genes were differentially expressed in GV oocytes between the youngest (25-30 years) and oldest (39-43 years) age groups when an unadjusted significance threshold of 0.01 was applied, but none of these differences remained significant after correcting for multiple testing (Supplementary Table SI) . None of the differentially expressed genes from any of the other age group comparisons surpassed the threshold after correcting for multiple testing.
Since age is continuous rather than categorical, we also carried out linear regression analysis for individual gene expression patterns with age (year) as a categorical variable. This revealed 171 genes that surpassed the unadjusted significance threshold of 0.01 (Supplementary  Table SII) . Again, none of these genes surpassed the significance threshold of 0.05 after correcting for multiple testing, and thus not a single gene could be identified as significant differentially expressed on a longitudinal scale with age per year.
Exploratory analysis
Although we did not observe any significant differences in gene expression between the different age groups at the present significance thresholds, we nevertheless wished to explore whether differences were present if significance settings were applied as described in a previously reported study (Grondahl et al., 2010) . When we applied an unadjusted significance threshold of 0.05 and a fold change larger than 1.5, a total of 37 genes were expressed differentially in GV oocytes between the youngest (25-30 years) and oldest (39-43 years) age group (Supplementary Table III ). Compared to the youngest age group, 19 genes were up-regulated and 18 genes were down-regulated in the oldest age group. The number of differentially expressed genes was too small for enrichment analysis. Of these 37 differentially expressed genes, 18 genes also surpassed the previous unadjusted significance threshold of 0.01 before being adjusted for multiple testing.
Analysis of gene expression dynamics
Since the effect of female age on fertility follows a particular dynamic over time, we also analysed gene expression dynamics in GV oocytes over time. The robustness check was inconclusive and revealed no clear number of K clusters and the number of K-mean clusters was therefore chosen by eyeballing. We grouped the 15 357 genes into 15 clusters according to their expression dynamics (Fig. 2) and showed expression dynamics that mimic either directly or inversely the effect of age on fertility. Clusters 6, 10, 12, 13 and 15 follow the expected pattern for age-related female fertility. Three of these clusters, including 3 470 genes, revealed decreasing gene expression patterns with advancing age (clusters 6, 12 and 15) and two clusters, with 2339 genes, showed increasing gene expression patterns with increasing female age (clusters 10 and 13). The significantly enriched biological processes (enrichment score >1.3) for these clusters were associated with, for example, placenta development, cell cycle and metabolic processes and are shown in Fig. 2B . Because the effect of female age on fertility becomes more pronounced after the age of 38, we also performed a clustering analysis on genes whose expression levels were up-or down-regulated only in the oldest age group (38-43 years) when compared to the younger age groups (25-37 years). Within this analysis, genes were only included when similarly expressed (maximum 10% difference in logFC) between the three younger age groups (Fig. 3) . There were 31 genes that followed this pattern. Compared to the younger age groups, 18 genes were up-regulated and 13 genes were down-regulated in the oldest age group. The number of genes identified in the gene expression dynamics analysis was too small to be subjected to gene function enrichment analysis to determine which main functional properties were affected by age.
Discussion
It has long been postulated that molecular alterations expressed as differential gene expression patterns underlie the decreased fertility in older women compared to younger women. As far as we know, we conducted the largest study to date determining the gene expression profiles in single human GV oocytes from women of different ages. Contrary to our expectations, we did not observe any significant differences in gene expression profiles of GV oocytes in relation to female age.
The purpose of this study was to investigate the relationship between gene expression profiles of GV oocytes in relation to female age and subsequently to generate a molecular-based hypothesis for the age-related decrease in female fertility. However, the hierarchical cluster diagram and MDS plot showed that the studied GV oocytes could not be clustered based on their gene expression profiles in relation to female age, AFC or total dosage of FSH used in ovarian stimulation. Likewise, class comparisons of the gene expression profiles of individual GV oocytes between the four age categories and regression analysis revealed no differentially expressed genes after correcting for multiple testing. Even after lowering significance thresholds, no significant differences were observed (data not shown).
The strengths of our study include the largest sample size so far and wide age range (25-43 years) of single GV oocytes analysed. The applied microarray technology used in this study has previously been validated with a demonstrated correlation coefficient of more than 95% in pooled and split samples (Mantikou et al., 2016) . The findings of this technique are therefore assumed to reflect true biological variations or, in this case, the absence of such variation in human GV oocytes.
At the experimental set up, a power calculation could not be performed, since at that time, there were no previous studies that had performed whole transcriptome analyses of single GV oocytes in relation to female age. Reyes et al. (2017) published a study comparing gene expression profiles of GV and M II oocytes of women <30 and ≥40 years of age. Here, 5 GV and M II oocytes of young women were compared to 5 GV and M II oocytes of older women. Only one gene (RP11-404K5) was differentially expressed in older versus young GV oocytes. In our analysis, the RP11-404K5 gene was not significantly differentially expressed in GV oocytes of young and old women. This could be due to chance or to the use of different techniques. Overall, our results are consistent with the results of Reyes et al. Different whole transcriptome analysis techniques have specific drawbacks. The gene expression microarray technique does not measure all possible oocyte-expressed transcripts, due, for example, to alternative RNA processing (Leff et al., 1986) .
Even when the above is taken into account, it is still possible that differences in gene expression between individual GV oocytes of women Figure 3 Clustering analysis on genes which expressions were up-or down-regulated only in the oldest age group (38-43 years) when compared to the younger age groups (18-37 years). Genes were only included when similarly expressed (maximum 10% difference in logFC) between the three younger age groups and differentially expressed in the oldest age group. (A and B) List and figure of genes that followed this expected pattern between the three younger and the oldest age. Genes which were up-regulated in the oldest age group are shown in green, down-regulated genes are shown in orange.
of different ages exist but that those differences were too small to be identified. A larger sample size might reveal these differences. Nevertheless, our dataset can be useful in designing a new powered future study to detect small differences in gene expression profiles of GV oocytes of women of different reproductive ages.
A limitation of this study is the use of GV oocytes rather than M II oocytes. After stimulating oocyte maturation by triggering ovulation, the GV oocytes in our study clearly did not continue meiosis and remained arrested. One can hypothesize that oocytes that remain arrested at the GV stage have impaired gene expression and therefore do not lead to any significant results in this study. We cannot exclude that our findings do not reflect the expression profiles of M II oocytes which are metabolically active and ready to be fertilized. On the other hand, GV oocytes represent the resting pool of oocytes arrested in prophase I in the human ovary while female age progresses. In addition, they are readily available as leftovers from ICSI treatments whereas M II oocytes are more difficult to obtain since they are used by the patients for the purpose of a pregnancy through IVF/ICSI. Previous studies that have looked at gene expression profiles of M II oocytes were limited to M II oocytes that did not appear to be fertilized after overnight incubation post sperm insemination (IVF) or injection (ICSI) (Steuerwald et al., 2007) . Here also, these oocytes do not reflect 'normal M II' oocytes. One other study used in-vitro matured M II oocytes (Reyes et al., 2017) . In-vitro matured M II oocytes show a more similar expression profile to immature (GV) oocytes, compared to in-vivo matured oocytes (Wells and Patrizio, 2008) . In-vitro matured M II oocytes are therefore also not ideal research material. Only Grondahl et al. (2010) used fresh M II oocytes that were selected before fertilization, but they could only include 15 M II oocytes. Studies with low statistical power have a reduced chance of detecting a true effect (Button et al., 2013) . Clearly, avoiding any form of limitation when working with human oocytes is extremely challenging and results should be put in the context of these limitations.
The IVF treatment and laboratory manipulations, such as ovarian stimulation or culture conditions might also have an effect on the gene expression profile of GV oocytes (Virant-Klun et al., 2013) . For example, within IVF/ICSI treatments, women are exposed to different levels of exogenous FSH to stimulate follicle growth. As shown in Table I , the amount of FSH needed to stimulate follicular growth is age dependent. In the natural menstrual cycle, FSH also increases age dependently, but this increases is more subtle (Wiweko et al., 2013) . After oocyte retrieval, GV oocytes were subjected to similar conditions. It is possible that gene expression profiles of these GV oocytes were altered by these treatment factors in such a way that small differences in gene expression profiles among GV oocytes would disappear.
To the best of our knowledge, only three published studies have examined the competence of human oocytes directly in relation to female age with whole genome gene expression analyses (Steuerwald et al., 2007; Grondahl et al., 2010; Reyes et al., 2017) . All three studies reported significant changes in gene expression in M II oocytes from young and older aged women. However, in two out of three studies, the results were not reported as adjusted P-values or q-values, and correction for multiple testing was not mentioned in the data analyses sections (Steuerwald et al., 2007; Grondahl et al., 2010) . This should be considered when interpreting those studies. Microarray technology measures gene expression levels for thousands of genes on the array simultaneously and this may result in differential expression of a large number of genes as a result of multiple testing error. In our explorative analysis, we examined whether large differences in gene expression would be found when thresholds were changed into previously reported cut-offs (P < 0.01 vs P < 0.05 and log FC > 1.5). Comparing the results between these two cut-offs showed that only 18 out of 189 genes were consistent with the genes that surpassed the unadjusted significance threshold of 0.01 before multiple testing. Therefore, the control of false positive rates by correcting for multiple testing and adequate description of the method of analysing are important to report.
Analysing clusters of genes that mimicked either directly or inversely the effect of female age on fertility based on their expression levels, identified genes that were associated with placenta development, cell cycle and metabolic processes. Alteration in these processes could lead to impaired fertilization, embryo development and implantation (Keefe et al., 2015) . These processes could possibly be attributed to the age-related decline in female fertility. Our conclusions, however, should be interpreted with caution, since these levels are based on expression levels and no statistical tests were performed on these results. This is the first article that only investigated gene expression of GV oocytes. Previous literature published on age-related gene expression differences between human M II oocytes (Table I) identified numerous genes differentially expressed in the mature oocyte. This could indicate that differences in oocyte quality between young and old women only become apparent during oocyte maturation, which could explain the reported differences in, for example, ooplasmic volume and mtDNA content between mature oocytes (Murakoshi et al., 2013) . Specific groups of genes are expressed in different developmental stages of oocyte maturation (Wells and Patrizio, 2008; Xue et al., 2013) . So far, developmental stage and age-related differences in gene expression of in-vivo collected human oocytes combined have not yet been described. Alternatively, the effect of age on oocyte quality might not be at all mediated through altered gene expression patterns in oocytes.
We conclude that we could not find significantly different gene expression profiles of human GV oocytes in relation to female age. Since other studies have suggested that gene-expression profiles are affected by age in mature oocytes, this might imply that female age affects oocyte maturation. Alternatively, there may be other mechanisms in human oocytes causing the age-related decline in fertility. Given the importance of female age on fertility as well as treatment success, further research into the molecular mechanisms underlying this phenomenon is warranted.
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